• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

What are the effects of systemic therapies for the prevention and treatment of aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer? - A Cochrane Review summary with commentary.

作者信息

Sen Ekin Ilke

机构信息

Department of Physical Medicine and Rehabilitation, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

出版信息

J Musculoskelet Neuronal Interact. 2022 Sep 1;22(3):301-304.

PMID:36046985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9438519/
Abstract
摘要

相似文献

1
What are the effects of systemic therapies for the prevention and treatment of aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer? - A Cochrane Review summary with commentary.全身治疗对早期乳腺癌中芳香化酶抑制剂所致肌肉骨骼症状的预防和治疗效果如何？——Cochrane系统评价总结及述评
J Musculoskelet Neuronal Interact. 2022 Sep 1;22(3):301-304.
2
Management of aromatase inhibitor induced musculoskeletal symptoms in postmenopausal early Breast cancer: A systematic review and meta-analysis.绝经后早期乳腺癌芳香化酶抑制剂引起的肌肉骨骼症状的管理：系统评价和荟萃分析。
Crit Rev Oncol Hematol. 2017 Mar;111:66-80. doi: 10.1016/j.critrevonc.2017.01.010. Epub 2017 Jan 22.
3
Aromatase inhibitors and musculoskeletal pain in patients with breast cancer.芳香化酶抑制剂与乳腺癌患者的肌肉骨骼疼痛
Clin J Oncol Nurs. 2007 Jun;11(3):433-9. doi: 10.1188/07.CJON.433-439.
4
Aromatase inhibitor associated musculoskeletal symptoms are associated with reduced physical activity among breast cancer survivors.芳香酶抑制剂相关的肌肉骨骼症状与乳腺癌幸存者身体活动减少有关。
Breast J. 2014 Jan-Feb;20(1):22-8. doi: 10.1111/tbj.12202. Epub 2013 Oct 25.
5
Aromatase inhibitor induced musculoskeletal syndrome: a significant problem with limited treatment options.芳香化酶抑制剂诱发的肌肉骨骼综合征：一个治疗选择有限的重大问题。
Support Care Cancer. 2016 May;24(5):2139-2146. doi: 10.1007/s00520-015-3001-5. Epub 2015 Nov 10.
6
Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study.他莫昔芬治疗 2-3 年后接受依西美坦或他莫昔芬治疗的早期乳腺癌绝经后妇女的腕管综合征和肌肉骨骼症状：分组研究的回顾性分析。
Lancet Oncol. 2012 Apr;13(4):420-32. doi: 10.1016/S1470-2045(11)70328-X. Epub 2012 Jan 20.
7
Single arm phase II study of oral vitamin B12 for the treatment of musculoskeletal symptoms associated with aromatase inhibitors in women with early stage breast cancer.口服维生素B12治疗早期乳腺癌女性中与芳香化酶抑制剂相关的肌肉骨骼症状的单臂II期研究。
Breast J. 2018 May;24(3):260-268. doi: 10.1111/tbj.12951. Epub 2018 Feb 14.
8
Exercise Therapies for Preventing or Treating Aromatase Inhibitor-Induced Musculoskeletal Symptoms in Early Breast Cancer.
Clin Nurse Spec. 2021;35(4):167-168. doi: 10.1097/NUR.0000000000000600.
9
Bone loss and the aromatase inhibitors.骨质流失与芳香化酶抑制剂
Br J Cancer. 2005 Aug;93 Suppl 1(Suppl 1):S16-22. doi: 10.1038/sj.bjc.6602691.
10
Update on aromatase inhibitors in breast cancer.乳腺癌中芳香化酶抑制剂的最新进展
Curr Opin Obstet Gynecol. 2006 Feb;18(1):41-6. doi: 10.1097/01.gco.0000192973.54105.86.

本文引用的文献

1
Impact of exercise interventions on physical fitness in breast cancer patients and survivors: a systematic review.运动干预对乳腺癌患者和幸存者身体适应性的影响：系统综述。
Breast Cancer. 2022 May;29(3):402-418. doi: 10.1007/s12282-022-01347-z. Epub 2022 Mar 12.
2
Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.用于预防或治疗早期乳腺癌中芳香化酶抑制剂引起的肌肉骨骼症状的系统治疗。
Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD013167. doi: 10.1002/14651858.CD013167.pub2.
3
Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management.芳香酶抑制剂相关的肌肉骨骼综合征：机制与管理。
Front Endocrinol (Lausanne). 2021 Jul 27;12:713700. doi: 10.3389/fendo.2021.713700. eCollection 2021.
4
Management of Aromatase Inhibitor-Induced Musculoskeletal Symptoms.芳香化酶抑制剂所致肌肉骨骼症状的管理
JCO Oncol Pract. 2020 Nov;16(11):733-739. doi: 10.1200/OP.20.00113. Epub 2020 Aug 11.
5
Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.用于预防或治疗早期乳腺癌中芳香化酶抑制剂所致肌肉骨骼症状的运动疗法
Cochrane Database Syst Rev. 2020 Jan 29;1(1):CD012988. doi: 10.1002/14651858.CD012988.pub2.
6
The effect of exercise on aromatase inhibitor-induced musculoskeletal symptoms in breast cancer survivors :a systematic review and meta-analysis.运动对乳腺癌幸存者芳香化酶抑制剂引起的肌肉骨骼症状的影响：系统评价和荟萃分析。
Support Care Cancer. 2020 Apr;28(4):1587-1596. doi: 10.1007/s00520-019-05186-1. Epub 2019 Dec 18.
7
Prevalence of aromatase inhibitor-induced arthralgia in breast cancer: a systematic review and meta-analysis.芳香化酶抑制剂所致乳腺癌关节痛的患病率：一项系统评价与荟萃分析
Support Care Cancer. 2017 May;25(5):1673-1686. doi: 10.1007/s00520-017-3613-z. Epub 2017 Feb 15.
8
Symptoms: Aromatase Inhibitor Induced Arthralgias.症状：芳香化酶抑制剂诱发的关节痛。
Adv Exp Med Biol. 2015;862:89-100. doi: 10.1007/978-3-319-16366-6_7.
9
Aromatase inhibitor associated musculoskeletal symptoms are associated with reduced physical activity among breast cancer survivors.芳香酶抑制剂相关的肌肉骨骼症状与乳腺癌幸存者身体活动减少有关。
Breast J. 2014 Jan-Feb;20(1):22-8. doi: 10.1111/tbj.12202. Epub 2013 Oct 25.
10
Five or more years of adjuvant endocrine therapy in breast cancer: a meta-analysis of published randomised trials.乳腺癌辅助内分泌治疗 5 年以上：已发表随机试验的荟萃分析。
Breast Cancer Res Treat. 2013 Jul;140(2):233-40. doi: 10.1007/s10549-013-2629-4. Epub 2013 Jul 17.